Showing results (1841-1850 of 9,136) with videos related to

Sort By:
Pageof 914
Cancer Medicine|March 28, 2024
Comparison of the multiples of the median of serum anti-müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case-control studyTheodora Hei Tung Lai, Lesley Suk Kwan Lau, Siew Fei Ngu, et al.
Cancer Medicine|April 13, 2024
PD-L1 inhibitors combined with whole brain radiotherapy in patients with small cell lung cancer brain metastases: Real-world evidenceLitang Huang, Shen Chen, Hui Liu, et al.
Cancer Medicine|April 17, 2024
Current treatment and novel insights regarding ROS1-targeted therapy in malignant tumorsShizhe Li, He Zhang, Ting Chen, et al.
Cancer Medicine|April 9, 2024
The impact of the affordable care act and Medicaid expansion on colorectal cancer screening: Evidence from the 5th year of Medicaid expansionMichael A Preston, Mahmoud Manouchehri Amoli, Askar S Chukmaitov, et al.
Cancer Medicine|April 9, 2024
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer: A phase II trial (HYBRID)Hiroyuki Arai, Takashi Tsuda, Yu Sunakawa, et al.
Cancer Medicine|March 22, 2024
Retrospective analysis of real-world prescribing data for managing cisplatin-based chemotherapy-induced nausea and vomiting in ChinaXia Si, Hongyan Zhang, Qingming Ding, et al.
Cancer Medicine|March 20, 2024
Body composition change indices combined with Prognostic Nutritional Index predicts the clinical outcomes of patients with gastric cancer treated with immune checkpoint inhibitorGuiming Deng, Dayong Zhu, Zhongze Du, et al.
Cancer Medicine|March 20, 2024
Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic eraAlexandre Iat, Michael Loschi, Sami Benachour, et al.
Cancer Medicine|March 25, 2024
Nomogram for predicting pathological response to neoadjuvant treatment in patients with locally advanced gastric cancer: Data from a phase III clinical trialHan Shao, Nai Li, Yi-Hong Ling, et al.
Cancer Medicine|April 4, 2024
Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancerRyosuke Uekusa, Akira Yokoi, Eri Watanabe, et al.
Pageof 914